The new Massachusetts AI and Technology Center for Connected Care in Aging and Alzheimer’s Disease, or MassAITC, at the University of Massachusetts Amherst distributed $1.7 million in National Institute on Aging funding Jan. 9 to its first seven pilot projects:
1. Testing a vocal biomarker platform for remote detection and monitoring of cognitive impairment (Massachusetts General Hospital and Sonde Health).
2. Sensor-guided psychopharmacology for Alzheimer’s and related dementias (Belmont, Mass.-based McLean Hospital).
3. Early acute-illness detection for delirium and dementia (Beth Israel Deaconess Medical Center and Boston-based Northeastern University).
4. Smartphone blood pressure monitoring for healthy aging (University of California San Diego).
5. Developing real-world digital biomarkers from wearable sensors for Alzheimer’s (UMass Amherst and VivoSense).
6. Detecting frailty at home through noninvasive, whole-room, body-heat sensing (UMass Amherst, Hebrew SeniorLife and Butlr Technologies).
7. Vascular aging using infrasonic hemodynography embedded into earbuds (MindMics).
